RiviaCo’s Post

Did you know that HealthCap Africa's portfolio companies have created 13,000 direct and indirect jobs? Through strategic investments and support, HealthCap Africa is not only fostering innovation but also driving job creation across the healthcare and finance sectors.

Did you know that HealthCap Africa's portfolio companies have created 13,000 direct and indirect jobs? 🤔 Through strategic investments and support, HealthCap Africa is not only fostering innovation but also driving job creation across the healthcare and finance sectors. . #venturecapital #jobcreation

🌍 Why is Dr.Guido not just a business investment, but also a crucial social investment? DrGuido offers more than just a technological solution – it provides vital first-step medical support in developing countries where healthcare infrastructure is often lacking. In regions with limited access to doctors and healthcare services, DrGuido becomes a reliable informative gateway to medical assistance. We are receiving significant interest from South America, South Africa, and parts of Asia, where local authorities and organizations see DrGuido as an opportunity to offer a virtual doctor to low-income populations and those facing challenges in accessing healthcare services. This initiative also helps to alleviate the shortage of medical professionals in these areas. By investing in DrGuido, you are not only supporting an innovative tech solution but contributing to global health equity and making a real difference in underserved communities. Meet DrGuido at the upcoming Web Summit in Lisbon! https://lnkd.in/dq75s-Tv #SocialImpact #AIHealthcare #DrGuidoAI #GlobalHealth #TechForGood #HealthcareInnovation #BusinessWithPurpose

Recently, I had an engaging discussion with colleagues about the healthcare landscape in Africa, particularly focusing on the relationship between big pharma and developing economies in terms of drug development. We debated how these dynamics often leave many without access to advanced treatments. Amidst this conversation, the concept of clinical research as a care option (CRAACO) emerged as a beacon of hope. CRAACO integrates clinical research directly into patient care, offering a dual benefit: patients receive innovative treatments while contributing to scientific progress. This approach could be a game-changer for Nigeria. Imagine a Nigerian patient with a rare condition: traditionally, their options are limited. But, through CRAACO, they can access cutting-edge therapies available only through clinical trials. This not only provides immediate health benefits but also fosters a more robust healthcare infrastructure. Key Benefits: 1. Access to Advanced Treatments: Patients receive the latest therapies. 2. Enhanced Infrastructure: Boosts healthcare facilities and professional training. 3. Economic Growth: Attracts investments and creates jobs. 4. Improved Health Outcomes*: Empowers patients with diverse treatment options. Challenges persist: ensuring strong regulatory and ethical standards, raising public awareness, and securing necessary funding are pivotal. But with collaboration between government, healthcare providers, and international partners, these obstacles can be overcome. Embracing CRAACO could transform healthcare in Nigeria, providing access to better treatments and driving economic growth. Let’s continue this conversation and explore how CRAACO can redefine healthcare in developing economies. Share your thoughts below! #HealthcareInnovation #ClinicalResearch #NigeriaHealthcare #CRAACO #MedicalResearch #HealthEquity

🌍 Acting as a one-stop shop, Oximio (Formerly SMO Group) African operations, are making new inroads into #clinicaltrials via a wave of initiatives designed to streamline and enhance the clinical trial supply chain on the continent. 👉 Find out what these entrepreneurial initiatives are and why #Africa has become a key contender in the clinical trials market. Download are latest eBook and white paper: https://lnkd.in/eD8fz8DB 💡Re-shaping the Clinical Supply Chain in sub-Saharan Africa 💡Unlocking the clinical trial potential of Africa

Clinical trials need to be done in Africa. Africa needs more experts in Clinical trials

💊Are you interested in getting your management team empowered and invested in their journey? 💊Are you interested in understanding how to streamline your business processes so that your company can get accredited? 💊And finally, do you do drugs when you fall ill? Then sign up! When else will you get to see world-class medicine manufacturing facilities in Kenya? Contact us for more details on where to sign up for our events. #EOKenya

📅 Reminder for 2025 SAHPRA Submission Deadlines! 📅 Attention CROs and sponsors! With the 2025 SAHPRA submission schedule now available, make sure to plan ahead and stay on track with your clinical research submissions in South Africa. Early preparation can ensure smooth approvals and successful project timelines! Let’s make 2025 a year of progress in advancing healthcare together! #ClinicalResearch #SAHPRA #SouthAfrica #HealthcareInnovation #ResearchApproval

join the session to know more about the "Pakistan Clinical Research Landscape, a CRO Perspective"

Digitalising healthdata should be a priority for low and middle income countries. New technologies make it economically possible. To be continued…